Archive | October, 2007

RNA-interference Used To Develop New Contraceptive That Blocks Sperm Entry

A novel contraceptive patch without the unpleasant side effects of traditional contraceptive pills, such as mood swings, weight gain, and cancer risk, is currently being developed by a team of U.S scientists working at the Brigham and Women’s Hospital in Boston.

Continue Reading

Posted in Biotechnology, Clinical Research, Drug Development, Fertility, Genomics, Gynecology, Medical Devices, Medical Technology, Molecular Biology, Pharma, Pharmacology, Women's Health0 Comments

Multifactorial Etiology And Risk Factors Of Osteoradionecrosis Uncovered

Osteoradionecrosis (ORN) is one of the most serious adverse effects of oral radiation therapy, but its etiology, risk factors, and pathogenesis has been hazy. Now, in a recent study, Goldwaser BR and colleagues at the Department of Oral and Maxillofacial Surgery, Harvard School of Dental Medicine, Boston, published in the upcoming issue of Journal of Oral and Maxillofacial Surgery, have assessed the various risk factors associated with osteoradionecrosis.

Continue Reading

Posted in Dental Science, Head and Neck, Maxillofacial Surgery, Oncology, Orthopedics, Radiotherapy0 Comments

Cannabis Is Useful In The Treatment of Depression And Neuropathic Pain

In two independent studies conducted at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR) and the McGill University, Montreal, Canada, researchers have demonstrated that moderate doses of Cannabis helps in reducing neuropathic pain and also acts as an antidepressant.

Continue Reading

Posted in Clinical Research, Drug Development, Emergency Medicine, Internal Medicine, Mental Health, Pharma, Pharmacology, Psychiatry, Psychology0 Comments

Influenza Vaccination Benefits The Elderly Population

Influenza is a significant contributor to the morbidity and mortality in the elderly population, and over 44,000 deaths are attributed to the disease each year. Administration of annual influenza vaccines to the elderly has been a public health strategy since several years. Surprisingly, the rate of winter hospitalizations and deaths went up as the rates of vaccination increased in the US (Simonsen et al; Archives of Internal Medicine, 2005), which cast a shadow of doubt on the efficacy of the influenza vaccine. Now, a team led by Kristin L Nichol from the Medicine Service and Center for Chronic Disease Outcomes Research, Minneapolis Veterans Affairs Medical Center and University of Minnesota, Minneapolis, (The New England Journal of Medicine, October 2007), based on the results of a large 10-year long trial, have reiterated the importance and benefits of the influenza vaccine in the elderly.

Continue Reading

Posted in After 60, Chest, ENT, Emergency Medicine, Geriatrics, Immunology, Infectious Diseases, Internal Medicine, Microbiology, Pharma, Pharmacology, Pulmonology0 Comments

Testing For HPV-DNA Is Better Than Pap Smear In Screening For Cervical Cancer

Cervical cancer is the second most common cancer in women and an important cause of mortality and morbidity in women. Infection with oncogenic HPV strains is known to precede cytological changes that culminate in cervical cancer. The Papanicolaou test (Pap Smear) is a commonly used screening test which has helped in reducing the incidence of invasive cervical cancer. However, the sensitivity of the smear test mandates repeated testing. In a recent study, published in the latest issue of the New England Journal of Medicine, scientists have shown that testing for the HPV-DNA is superior to Pap smear for the detection of cervical intraepithelial neoplasia (CIN).

Continue Reading

Posted in Gynecology, Infectious Diseases, Lab Medicine, Oncology, Women's Health0 Comments

Phase 1 Study Shows Superior Efficacy Of IL-21 And Sorafenib Combination In Renal Cell Cancer

A recent phase 1 trial, funded by ZymoGenetics Inc, using Interleukin-21 and Sorafenib (Nexavar® | OnyxBayer) combination therapy has demonstrated promising results in the treatment of renal cell cancer. In this study, the combination of IL-21 with the tyrosine kinase inhibitor, Sorafenib, showed superior antitumor activity and safety.

Continue Reading

Posted in Biotechnology, Biotherapeutics, Clinical Research, Drug Development, General Surgery, Genetics, Immunology, Internal Medicine, Nephrology, Oncology, Pharma, Pharmacology0 Comments

Early Use Of Prednisolone Improves Recovery In Bell’s Palsy

Bell’s palsy is an idiopathic unilateral facial nerve paralysis that affects 11-40 per 100000 individuals every year. Although the treatment of this condition remains controversial, acyclovir and oral steroids are commonly used despite lack of definitive data regarding their benefit. In the latest issue of the New England Journal of Medicine, Frank Sullivan from the Scottish School of Primary Care, Dundee, UK, and colleagues have published their study results which indicate that early treatment with prednisolone significantly improves the chances of complete recovery in Bell’s Palsy.

Continue Reading

Posted in Critical Care, ENT, Immunology, Internal Medicine, Neurology, Neurosurgery, Pharmacology0 Comments

Bedtime Administration Of Telmisartan Provides Better BP Control

Medications that show 24-hour efficacy in the treatment of hypertension not only improve compliance, but they also minimize blood pressure variability and provide consistent BP control. International guidelines recommend such once-daily medications for the treatment of hypertension. In a recent issue of Hypertension, Hermida and colleagues have shown that telmisartan (Micardis | Boehringer Ingelheim) administered at bedtime, as opposed to morning doses, offers better nocturnal BP regulation without any loss in the 24-hour efficacy.

Continue Reading

Posted in Cardiology, Clinical Research, Critical Care, Drug Development, Emergency Medicine, Endocrinology, Internal Medicine, Pharma, Pharmacology0 Comments

SonoSite’s S-ICUâ„¢ To Transform Imaging In The Critical Care Setting

SonoSite has launched a new ultrasound device from its S series stable, specifically for use in the Intensive Care Units, called the S-ICUâ„¢. Specially designed for the critical-care physicians, the S-ICUâ„¢ was showcased at the American College of Chest Physicians annual conference at the McCormick Place Convention Center in Chicago, from October 22-25, 2007.

Continue Reading

Posted in Critical Care, Emergency Medicine, Internal Medicine, Medical Devices, Medical Technology, Radiodiagnosis, Ultrasound0 Comments

Amlodipine Is Superior To Other Antihypertensives In Preventing Stroke

Antihypertensive medications play an important role in the prevention of cardiovascular events, including myocardial infarction and stroke. The protective effect is primarily attributed to their effect of lowering the systolic blood pressure. Several trials have compared the efficacy of the available antihypertensive drugs in the prevention of cardiovascular events. Recently, a team of researchers from the Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, led by Ji-Guang Wang, have reported (Hypertension; October, 2007) that amlodipine provides superior protection against stroke, when compared to diuretics, ß-blockers, ACE inhibitors, and angiotensin receptor blockers (ARBs).

Continue Reading

Posted in Biotechnology, Cardiology, Critical Care, Drug Development, Emergency Medicine, General Surgery, Geriatrics, Internal Medicine, Neurology, Neurosurgery, Patient Care, Pharma, Pharmacology0 Comments

Advert

Upcoming Events

Stay Updated Via Our Twitter Alerts

Follow mndalerts on Twitter

Categories

Archives